Tesla Investor Ross Gerber Calls On DEA To Reschedule Cannabis: 'Absurd We're Still Waiting'

Comments
Loading...
Zinger Key Points

It wasn’t long ago when Ross Gerber, president and CEO of Gerber Kawasaki Wealth and Investment Management and an enthusiastic Tesla Inc TSLA investor, said that the nine things he focuses on in his investment decisions included “things that used to be illegal,” one of which is cannabis.  

Since Gerber made that remark nearly two years ago, cannabis has become legalized in the vast majority of the country as Ohio became the 24th state to approve adult-use marijuana in November joining 38 others with legal medical marijuana. 

Bullish On Cannabis Stocks

Gerber said at the time that he was “super bullish” on cannabis stocks. “Sales are through the roof," he said. "They’ve already built an amazing industry, whether it’s Green Thumb GTBIF or TerrAscend TRSSF or Trulieve TCNNF in Florida. These are great businesses with great CEOs making tons of cash flow.” 

He's Got That Right

Now, two years later, a recent report by Zuanic & Associates highlighted both EBITDA and market cap upside of two of the three companies Gerber mentioned: Green Thumb, a leader in EBITDA Upside ($2,160M) and Trulieve with a market cap increase of over 150%. 

They’re still making “tons of cash flow” despite the onerous IRS tax code 280E that obliges cannabis companies to pay income tax on gross profits. The repeal of 280E could dramatically lower effective tax rates from over 70% to around 21%.

What’s To Be Done? 

If you said reschedule cannabis from Schedule 1 to Schedule 3, go to the head of the class. We are all waiting for that to happen, especially following an August recommendation from the Dept of Health and Human Services to the DEA to lighten up on cannabis. 

Ross Gerber, in a recent Tweet on X, has joined the chorus, calling it absurd that we're still waiting for cannabis rescheduling. 

He's got that right, too.

Photo from Benzinga Power Hour

TSLA Logo
TSLATesla Inc
$260.12-3.11%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum92.08
Growth67.62
Quality97.18
Value10.76
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs

Posted In:

Cannabis is evolving—don’t get left behind!

Curious about what’s next for the industry and how to stay ahead in today’s competitive market?

Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.

Secure your spot now before prices go up—this is where the biggest deals and connections happen!

Get your tickets today!